SCHEMBL7435442

SCHEMBL7435442

COC(=O)c1ccc(N2CCOCC2)c(N)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.75
NPC1 O15118 4/20 0.75
SMN1; SMN2 Q16637 4/20 0.75
RAB9A P51151 2/20 0.75
NPSR1 Q6W5P4 1/20 0.75
ALDH1A1 P00352 6/20 0.70
HPGD P15428 4/20 0.70
MAPT P10636 2/20 0.70
PRKDC P78527 1/20 0.60
KMT2A Q03164 2/20 0.56
HSD17B10 Q99714 5/20 0.55
GLA P06280 3/20 0.55
GAA P10253 3/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
ATM Q13315 1/20 0.55
ALOX15 P16050 1/20 0.52
MGLL Q99685 1/20 0.52
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23226763 0.89 NPC1 (0.59) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL7432215 0.87 KDM4E (0.97) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL17302722 0.86 NPC1 (0.61) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL31038267 0.86 KDM4E (1.00) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL195575 0.86 KDM4E (1.00) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL2773168 0.84 KMT2A (0.57) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL24266512 0.84 NPC1 (0.61) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL17395881 0.84 NPC1 (0.68) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL6597425 0.83 ALDH1A1 (0.56) KDM4ENPC1SMN1; SMN2RAB9ANPSR1
SCHEMBL16869527 0.83 KMT2A (0.58) KDM4ENPC1SMN1; SMN2RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638909-A Compounds with antibacterial activity 香港理工大学 2021-04-09 CN disclosed
CN-1037346-C Therapeutic agents BOOTS CO LTD (GB) 1998-02-11 CN disclosed
US-5373008-A Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents THE BOOTS COMPANT PLC. (GB) 1994-12-13 US disclosed
US-5223498-A Hypoglycemic agents THE BOOTS COMPANY PLC (GB) 1993-06-29 US disclosed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP disclosed
US-5210266-A Analgesic enkephalinase inhibitors DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-05-11 US disclosed
US-5179125-A Analgesics DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-01-12 US disclosed
CN-1057648-A Therapeutical agent BOOTS CO PLC (GB) 1992-01-08 CN disclosed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP disclosed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP disclosed